C-Met Inhibitors are Potential Novel Therapeutic Agents Against Listeria monocytogenes Infection Through Blocking the Bacteria Entry into Nonphagocytic Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|17|3|278-289

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.3, 2017-01, pp. : 278-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors

By Kilby J.M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1157-1170

Informa Healthcare

Access to resources Recommend Favorite

MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-01 ,pp. : 975-989

Bentham Science Publishers

Access to resources Recommend Favorite

Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic Agents

By  

Current Pharmaceutical Design, Vol. 13, Iss. 3, 2007-01 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic Agents

By  

Current Pharmaceutical Design, Vol. 13, Iss. 4, 2007-02 ,pp. : 405-414

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Small-Molecule Inhibitors of HCV NS3-4A Protease as Potential Therapeutic Agents against HCV Infection

By  

Current Medicinal Chemistry, Vol. 12, Iss. 20, 2005-09 ,pp. : 2317-2342

Bentham Science Publishers

Access to resources Recommend Favorite